Warren Marshelle Smith 4
4 · SQZ Biotechnologies Co · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Warren Marshelle Smith
Chief Medical Officer
Transactions
- Award
Stock Option
2022-06-01+200,000→ 200,000 totalExercise: $3.32Exp: 2032-06-01→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying securities on June 1, 2023 and in 36 substantially equal monthly installments thereafter.